Education, Science, Technology, Innovation and Life
Open Access
Sign In

Meta Analysis of Traditional Chinese Medicine in Treating Cholecystolithiasis and Network Pharmacological Analysis of High-Frequency Drug Pairs

Download as PDF

DOI: 10.23977/medcm.2023.050304 | Downloads: 112 | Views: 685

Author(s)

Zhao Linjing 1, Yin Taotao 1, Wang Guotai 2, Yang Xingwu 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, 712046, China
2 Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China

Corresponding Author

Yang Xingwu

ABSTRACT

Objective to explore the clinical efficacy of Traditional Chinese medicine (TCM) in the treatment of gallstones, and to study the mechanism of high-frequency drug pairs (Bupleurum chinense and Lysimachia charistinae) in the treatment of gallstones. Methods: A computer search was conducted to search The Cochrane Library, CNKI, VIP, Wanfang, CBM, PubMed, and Web of Science databases for meta-analysis of randomized controlled studies on TCM treatment of gallstones in recent ten years. According to the results of the heterogeneity test, appropriate models were selected to make the forest map and funnel map, and the literature quality was evaluated. Network pharmacologic analysis was performed for the drug pairs (Bupleurum chinense and Pennisetum chinens) that appeared most frequently in the included literature. Chemical components and targets of the two traditional Chinese medicines in the treatment of gallstones were screened out, GO analysis and KEGG analysis were performed, and the potential mechanism of action of the two traditional Chinese medicines in the treatment of gallstones was discussed. Results: Meta-analysis showed that there was a significant difference in the effective rate between traditional Chinese medicine and conventional medicine in the treatment of gallstones. After network pharmacological analysis, there were 14 chemical components and 90 targets in the treatment of gallstones by S. chinensis and Bupleurum. GO analysis revealed 578 biological processes, 53 cell compositions, and 104 molecular functions. KEGG analysis showed that the biological pathway of Bupleurum and Radix monstris in the treatment of gallstones involved cancer pathway and TNF signaling pathway. Conclusion: TCM treatment of gallstones can improve clinical efficacy, and TCM treatment of gallstones has important clinical significance. Gallstone is a common biliary system disease in China, and its incidence is increasing year by year [1]. Gallstones can lead to gallbladder cancer [2]. Gallbladder cancer is a highly malignant cancer. Therefore, attention should be paid to the treatment of gallstones. However, there are some sequelae in the surgical treatment of gallstones, such as the recurrence of gallstones, bile duct injury, postoperative infection, etc. [3]. Ursodeoxycholic acid, anti-inflammatory cholagogue tablets, Dankang capsules, and other commonly used drugs in the clinical treatment of gallstones are difficult to solve the problem of the root. The author believes that the treatment based on syndrome differentiation of traditional Chinese medicine, combined with the patient's physique, can not only achieve the effect of dissolving and removing stones, but also eliminate and prevent the recurrence of stones from the root. Now the author uses statistical analysis to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of cholecystolithiasis, and studies the potential mechanism of high-frequency traditional Chinese medicine based on the results of meta-analysis, to broaden new ideas for clinical conservative treatment of cholecystolithiasis.

KEYWORDS

Gallstone, Traditional Chinese Medicine (TCM), Meta Analysis, Network Pharmacologic Analysis

CITE THIS PAPER

Zhao Linjing, Yin Taotao, Wang Guotai, Yang Xingwu, Meta Analysis of Traditional Chinese Medicine in Treating Cholecystolithiasis and Network Pharmacological Analysis of High-Frequency Drug Pairs. MEDS Chinese Medicine (2023) Vol. 5: 25-36. DOI: http://dx.doi.org/10.23977/medcm.2023.050304.

REFERENCES

[1] Wang Qihan, Zhang Zhongwen, et al. Epidemiological survey of cholecystolithiasis in Shanghai. Gastroenterology, 2018, 23 (3): 252-257.
[2] Koshiol J, Gao YT, Dean M, et al. Association of Aflatoxin and Gallbladder Cancer. Gastroenterology, 2017, 153(2): 488-494. e1.
[3] Zhang Kai. Meta analysis of related factors of bile duct injury in laparoscopic cholecystectomy. Taiyuan: Shanxi Medical University, 2020.
[4] Wang Dandan. Clinical Study on Gall Disease No. 1 in Treating 60 Patients with Gallstone of Liver gallbladder Damp heat Type. Harbin: Heilongjiang University of Traditional Chinese Medicine, 2013.
[5] Wang Xiaoyun. Chen Guangyu. Observation on the efficacy of Jinhu Granule in the treatment of early gallstone. Hainan Medical Journal, 2016, 27 (9): 1511-1512.
[6] Yan Shaozhuo. Clinical observation of Chen Jin Paishi Decoction in the treatment of gallbladder stones of hepatobiliary damp heat type. Harbin: Heilongjiang College of Traditional Chinese Medicine, 2021.
[7] Wang Ping. Clinical Study on Lidan Fossil Recipe in Treating Cholecystolithiasis of Liver Depression and Spleen Deficiency. Taiyuan: Shanxi College of Traditional Chinese Medicine, 2017.
[8] Huang Dunhuang, Wu Yaonan 45 Cases of Gallstone Treated with Jianpi Lidan Decoction. Guangming Traditional Chinese Medicine, 2016, 31 (3): 350-351.
[9] Ji Chengfeng. 36 Cases of Gallstone Treated with Shugan Lidan Decoction. Chinese Journal of Integrated Digestion of Traditional Chinese and Western Medicine. 2012, 20 (7): 328-329.
[10] Kong Lin, Clinical Study on Modified Sini Sanjin Decoction in Treating Cholecystolithiasis of Qi Stagnation and Phlegm Obstruction Type. Jinan: Shandong University of Traditional Chinese Medicine, 2018.
[11] Zhang Zhuhao, Wu Zhaohuai, Cai Weijie, etc Clinical Observation on 40 Cases of Gallstone Treated with Qinggan Lidan Paishi Decoction. Medical Aesthetics and Beauty, (12): 688-689.
[12] Yi Xilei, Guo Lv.120 Cases of cholelithiasis: Investigation and analysis of TCM constitution differentiation. Journal of Modern Integrated Traditional Chinese and Western Medicine, 2013, 22 (4): 382-383
[13] Li Junxiang, Chen Xuan, Liang Jian, etc Consensus on Diagnosis and Treatment of Cholelithiasis with Integrated Traditional and Western Medicine (2017). Chinese Journal of Integrated Digestion of Traditional and Western Medicine, 2018, 26 (2): 132-138
[14] Zhang Jianyi, Liao Jinping, Zheng Qijin. Experience of Qiu Jianxing, the First National Famous Chinese Medicine, in Treating Cholelithiasis. Shizhen Traditional Chinese Medicine, 2020, 31 (10): 2519-2521
[15] Jiang Mengting. Research on the syndrome and treatment of cholelithiasis by Professor Zhou Zhongying based on data mining, Nanjing University of Traditional Chinese Medicine: 2019
[16] Chen Mengmeng, Xie Xushan. Professor Xie Xushan's experience in treating gallstones. Asia Pacific Traditional Medicine, 2015, 11 (8): 56-57
[17] Rabenstein T, Radespiel T, Radespiel-Troger M, Hopfner L, et al.Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones..Eur J Gastroenterol Hepatol, 2005, 17(6):629-639.
[18] Guarino M P,Cocca S,Altomare A,et al,Ursodeoxycholic acid therapy in gallbladder disease, a story not yet cpmpleted..World J Gastroenterol, 2013, 19(31):5029-5034.
[19] Fang BJ, Shen JY.Zhang H. et a1.Effect of emodin on mobility signal transduction system of gallbladder smooth muscle in Guinea pig with cholelithiasis.Asian Pac J Trop Med.2016.9(10):991—996.
[20] Li Jun, Cai Hong, Wang Junming, et al. Chemical constituents, pharmacological effects and clinical application of Lysimachia christinae. Journal of Gerontology, 2017, 37 (12): 6262-6264
[21] Wu Hongjuan, Li Chunlan, Ma Chunlan, et al. The effect of Lysimachia christinae on serum cholecystokinin receptor and vasoactive intestinal peptide levels in patients with gallstone. Journal of Modern Integrated Chinese and Western Medicine, 2017, 26 (25): 2793-2795
[22] Wu Haiyan. Pharmacological study and clinical application of Bupleurum chinense. Clinical rational drug use, 2018,11 (9A): 100-102
[23] Yan Meiling, Yang Liu, Hou Ejiao. Research progress on chemical constituents and pharmacological effects of Bupleurum chinense. Information on Traditional Chinese Medicine, 2018, 35 (5): 103-109
[24] Song Xiaoxue, Huang Jinfeng, Tian Ming, et al. Pharmacology and clinical application of Dachaihu decoction. Journal of Traditional Chinese Medicine, 2019, 47 (4): 112-116
[25] Gao Yunxiao, Li Ze, Yang Liu, et al. Exploring the mechanism of Chaihu rhubarb on the prevention and treatment of cholelithiasis based on network pharmacology and molecular docking. World Journal of Traditional Chinese Medicine, 2022, 17 (14): 447-454.
[26] Moazeni—Bistgani M, Imani R.Bile bacteria of patients with choleli—thiasis and theirs antibiogram.Acta Med Iran, 2013, 51(1 1):779—783.
[27] Zhang Tao. Research on the mechanism of Dachaihu decoction in treating calculous cholecystitis based on network pharmacology. Beijing, Beijing University of Traditional Chinese Medicine: 2021
[28] Yang Chaomao, Yang Zhixin, Ma Xiaoling. The mechanism of AGEs RAGE signaling pathway in diabetes nephropathy and research progress in traditional Chinese medicine. Journal of Traditional Chinese Medicine, 2019, 34 (9): 1864-1868
[29] Zhang Tao, Yang Chengcheng, Zhang Shaohui, et al. Study on the network pharmacology of Jiawei Dachengqi Decoction in the treatment of intestinal obstruction by activating blood circulation Chinese Journal of Integrated Traditional and Western Medicine Surgery, 2020,26 (05): 838-849
[30] Daniela Marino, Yvonne Angehrn, Sarah Klein, et al. Activation of the epidermal growthfactor receptor promotes lymphangiogenesis in the skin. Joumal of DemaoloialScience, 2013, 71(3).
[31] Zhao Yanmei, Zhang Jiankang, Cai Zhaobin, et al. Clinical research progress of Akt inhibitors  China Modern Applied Pharmacy, 2017,34 (04): 625-630
[32] Wang Cheng, Sun Peilong. Research progress on the causes of cholelithiasis. Journal of Hepatobiliary Surgery, 2018, 26 (2): 157-160
[33] Li Yao, Liu Hongnan, Yin Yulong Quercetin Scientific Observation, 2020, 15 (6): 67-70
[34] Chunlian T, Xin L, Yu C,et al. Investigation of the anti-inflammatory and antioxidant activities of luteolin, kaempferol, apigenin and quercetin. South African Journal of Botany, 2021, 137:257-264.
[35] Ma Na, Li Yajing, Fan Jiping. Research progress on pharmacological effects of quercetin. Journal of Liaoning University of Traditional Chinese Medicine, 2018, 20 (8): 221-224
[36] Ye Qing, Li Junnian, Yang Dongmei, et al. Effect of plant quercetin on the immune function of voles. Acta Veterinaria Sinica, 2019, 39 (1): 77-83
[37] Tian Ruixue, Sun Yaozong, Yao Youhao, et al. Effect of quercetin on immune function of immunocompromised mice. Chinese Journal of Modern Medicine, 2019, 21 (9): 13 - 16
[38] Chen Dan. Study on anti-inflammatory and analgesic effects of kaempferol and its mechanism. Nanjing: Nanjing University of Traditional Chinese Medicine, 2021
[39] Kim S,Jin C Y,Kim C,et al. Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF- κ B, blocking the TLR4 pathway and reducing ROS generation. International Journal of Molecular Medicine, 2018, 43(2):682-692.
[40] Ahmad Khan M, Sarwar A, Rahat R, et al. Stigmasterol protects rats from collagen induced arthritis by inhibiting proinflammatory cytokines. International Immunopharmacology, 2020, 85: 106642.
[41] Ma Na, Li Yajing, Fan Jiping Progress in pharmacological research of acacia. China Modern Applied Pharmacy, 2018, 35 (10): 1951-1595.
[42] Wang Yutong, Lu Guanhua Research progress in the treatment of cholelithiasis with traditional Chinese medicine. Journal of Liaoning University of Traditional Chinese Medicine, 2021, 23 (2): 138-141.
[43] Tong Guanzhen, Fu Xiaoping, Yang Yan, etc Research progress on distribution and pharmacological activity of epicatechin. Journal of Yunnan Agricultural University, 2018, 33 (2): 343-349.

Downloads: 4232
Visits: 167647

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.